May 29 (Reuters) - Bionomics Ltd (BNO) :
- FORMAL STRATEGIC REVIEW PERIOD IS COMPLETE
- A CAPITAL AND DEBT STRUCTURE REVIEW IS BEING CONDUCTED BY MANAGEMENT TO DETERMINE FEASIBILITY OF FUNDING FUTURE CLINICAL TRIALS
- ANTICIPATE REPORTING TOP LINE DATA OF EXPLORATORY BNC210 CLINICAL TRIAL FOR TREATMENT OF AGITATION IN ELDERLY PATIENTS BY END OF JUNE 2019
Add to My Watchlist
What is My Watchlist?